Core Insights - Baird Medical Investment Holdings Ltd. has successfully completed its first Microwave Ablation (MWA) procedure in Bangladesh, marking a significant advancement in non-surgical cancer therapies in the region [1][2][3] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on the research and development of surgical robotic systems and innovative surgical instruments [4] - The company is FDA 510(k)-certified and has its solutions utilized in over 30 prestigious hospitals and clinics across the United States, including Johns Hopkins Hospital and Weill Cornell Medicine [4] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [4] Recent Developments - The first MWA procedure in Bangladesh was led by Dr. Mofazzal Sharif Rasel, successfully treating a 65-year-old patient with a 6 cm liver tumor, who is reported to be recovering well [2][3] - The completion of this procedure signifies a new era of access to advanced treatment options for patients in South Asia, reflecting growing global confidence in Baird Medical's MWA technology [3] Strategic Goals - Baird Medical aims to strengthen its global presence through strategic collaborations with leading clinicians and medical institutions, enhancing access to innovative tumor treatment solutions [3]
Baird Medical Announces First Successful Liver Tumor Ablation in Bangladesh